Spotlight on…. high-resolution biology
High-resolution imaging and genomic technologies are changing the way we view the environment, cells, chromosomes and molecules. From super-resolution… Read more »
High-resolution imaging and genomic technologies are changing the way we view the environment, cells, chromosomes and molecules. From super-resolution… Read more »
When BMC was founded 20 years ago, a lot was different. The open access (OA) movement was still in its infancy, the digital movement towards both the production… Read more »
Posted on behalf of Ru Bains, assistant editor for Genome Medicine Breast cancer is the most common cancer in women worldwide, and it is the second most common… Read more »
Head and neck cancer is the sixth most common cancer worldwide, and head and neck squamous cell carcinoma (HNSCC) is the most frequent form. Certain subtypes of… Read more »
Later this year, Genome Medicine will publish a special issue on the topic of Single cell analysis: into the clinic. This issue will highlight the rapid… Read more »
Anti-inflammatory drugs are taken for many conditions including asthma, rheumatoid arthritis and colitis. The most common class of these drugs, glucocorticoids,… Read more »
To round off our series on the Metabolomics of disease, Genome Medicine’s Editor, Rebecca Furlong, talks to leading scientists Tim Veenstra, David Wishart and… Read more »
Debates rage over why multiple large-scale studies to uncover risk factors for stroke have so far explained only a tiny proportion of inherited stroke cases and… Read more »
Efforts to predict and monitor drug response in individuals and in the population have increased markedly over the past few years, but there is a need for… Read more »
What is metabolomics and how is it being used to predict and manage disease? That’s the subject of Genome Medicine‘s and BioMed Central’s first… Read more »